The "Wolverine Stack" has become research shorthand for the BPC-157 + TB-500 combination — named for the fictional X-Men character whose defining characteristic is near-instantaneous tissue repair. While the comparison is obviously hyperbolic, the underlying science of combining these two peptides reflects genuine mechanistic thinking: BPC-157 and TB-500 heal tissue through fundamentally different pathways, and combining them provides coverage that neither achieves alone.
The nickname reflects the regenerative scope of the combined protocol in preclinical research models. In isolation, BPC-157 shows remarkable gut healing, tendon repair, and angiogenesis. TB-500 demonstrates systemic repair cell recruitment, cardiac healing, and anti-fibrotic effects. Together, they cover soft tissue, organ, cardiac, neural, and musculoskeletal healing research — a breadth that earned the Marvel character comparison in the research community's informal naming conventions.
BPC-157 (Body Protection Compound-157) works primarily at the site of injury by:
The result is a local healing environment that is biochemically primed for repair: new blood vessels delivering nutrients and oxygen, activated fibroblasts producing collagen, and growth factor signaling driving tissue regeneration. BPC-157 essentially builds the scaffold and wires in the plumbing for repair.
TB-500 (Thymosin Beta-4 fragment) works through actin sequestration — binding G-actin monomers and promoting the cytoskeletal dynamics that drive cell migration. The practical result is that repair cells (stem cells, endothelial cells, immune cells) migrate directionally toward injury sites at accelerated rates. TB-500 recruits the repair crew that BPC-157's local signals are calling for.
Critically, TB-500 distributes systemically — it doesn't just work locally. This systemic distribution means its cell-recruitment effects operate throughout the organism, not just at the primary injury site, which may explain its documented cardiac and neural repair activity far from typical musculoskeletal injury sites.
BPC-157 tendon healing (Sikiric et al.): In the most-cited BPC-157 tendon study, complete Achilles tendon transection in rats was followed by dramatically accelerated healing, improved biomechanical properties, and organized collagen fiber deposition in BPC-157-treated animals versus controls. Load-to-failure was significantly higher in treated animals. J Physiol Paris series.
TB-500 cardiac healing (Bock-Marquette et al., Nature 2004): Thymosin Beta-4 (parent protein of TB-500 sequence) injected after myocardial infarction in mice promoted cardiomyocyte migration, survival signaling activation (Akt pathway), and significantly improved cardiac function markers vs controls. One of the highest-impact papers in the cardiac regeneration literature. Nature, 2004.
BPC-157 gut healing: Decades of research from the Sikiric laboratory demonstrate BPC-157's consistent effects on gastric ulcer healing, intestinal fistula closure, and inflammatory bowel disease markers — often with dramatic effect sizes compared to standard-of-care comparators in animal models. The gut healing literature for BPC-157 is arguably its most robust application domain. Multiple publications, 1990s–present.
Both ≥99% purity · Third-party HPLC verified · Lot-specific COA · Ships 24–48h USA
Buy BPC-157 → Buy TB-500 →